ASSOCIATION BETWEEN HEPARIN DOSE AND 6-WEEKS MORTALITY IN PATIENTS WITH COVID-19
Background and Objectives Severe forms of SARS-CoV-2 infections are associated with high rates of thromboembolic complications. Professional societies and expert consensus reports have recommended the use of anticoagulants for COVID-19 hospitalized patients. Our study aimed to compare the effect...
Saved in:
| Main Authors: | Claire Coutureau, Philippe Nguyen, Maxime Hentzien, Peter Joe Noujaim, Sarah Zerbib, Damien Jolly, Lukshe Kanagaratnam |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
PAGEPress Publications
2022-04-01
|
| Series: | Mediterranean Journal of Hematology and Infectious Diseases |
| Subjects: | |
| Online Access: | https://www.mjhid.org/index.php/mjhid/article/view/4957 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Different doses of the first dose of heparin anticoagulation effect in maintaining hemodialysis patients
by: YU Xu-fang, et al.
Published: (2016-01-01) -
Multifaceted role of heparin in oncology: from anticoagulation to anticancer mechanisms and clinical implications
by: Niranjan Koirala, et al.
Published: (2025-02-01) -
Anticoagulant, anti-inflammatory, antiviral and antitumor properties of heparins
by: V. O. Bitsadze, et al.
Published: (2021-07-01) -
Therapeutic-dose heparin combined with antiplatelets in noncritically ill patients with COVID-19: a secondary analysis of a multiplatform randomized controlled trial
by: Sylvain A. Lother, et al.
Published: (2025-05-01) -
Potential targets of heparin during progression and metastasis of malignant neoplasms
by: V. V. Malashchenko, et al.
Published: (2024-01-01)